GetTopicDetailResponse(id=288a111251dc, topicName=福司替尼, introduction=福司替尼, content=原發(fā)性免疫性血小板減少癥 福司替尼, image=null, comments=0, allHits=753, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Fri Feb 16 21:37:00 CST 2024, time=2024-02-16, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=486908, tagList=[TagDto(tagId=486908, tagName=福司替尼)], ipAttribution=陜西省, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2187695, encodeId=44fd218e69523, content=<a href='/topic/show?id=ce80104936d5' target=_blank style='color:#2F92EE;'>#原發(fā)性免疫性血小板減少癥#</a> <a href='/topic/show?id=288a111251dc' target=_blank style='color:#2F92EE;'>#福司替尼#</a>, objectTitle=AJH：福坦替尼對日本原發(fā)性免疫性血小板減少癥患者的長期治療：一項開放標簽擴展研究, objectType=article, longId=813251, objectId=30c381325161, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202301009/1696895568746_4754896.jpeg, objectUrl=/article/show_article.do?id=30c381325161, replyNumber=0, likeNumber=109, createdTime=2024-02-16, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=30c381325161, moduleTitle=AJH：福坦替尼對日本原發(fā)性免疫性血小板減少癥患者的長期治療：一項開放標簽擴展研究, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=30c381325161)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2024-02-16發(fā)表于陜西省
